Doppler imaging measurements are repeatable in OAG patients

Article

The repeatability of colour Doppler imaging (CDI) measurements in open-angle glaucoma (OAG) patients has been confirmed by a study published in Journal of Glaucoma.

The repeatability of colour Doppler imaging (CDI) measurements in open-angle glaucoma (OAG) patients has been confirmed by a study published in Journal of Glaucoma.

Dr Rita Ehrlich et al., Department of Ophthalmology, Indiana School of Medicine, Indianapolis, Indiana, USA, conducted a cross-sectional, observational study on 116 OAG patients involved in the Indianapolis Glaucoma Progression Study. At the same time of day to baseline measurements were recorded 1 to 2 weeks apart on all patients. CDi measurements of retrobulbar blood flow velocities and Pourcelot's vascular resistance index (RI) were analysed.

Intraclass correlation coefficient (ICC) between the 2 baseline measurements was determined. Other measurements included the calculation of RI and peak systolic and end diastolic blood flow velocities (PSV/EDV) in the ophthalmic (OA), central retinal (CRA), and nasal and temporal short posterior ciliary arteries (N/TPCA).

Measurements in the OA were all above 0.82 in the intraobserver ICC for the PSV, EDV and RI. Measurements in the CRA were both above 0.8 in the intraobserver ICC PSV and RI. EDV in the CRA was found to be 0.64.

Intraobserver ICC in the N/TPCA for the PSV, EDV, and RI measurements varied between 0.71 and 0.88. It was generally similar to the intraobsever ICC for the OA and the CRA, but lower than 0.7 in the EDV and RI.

If performed on OAG patients within 2 weeks the blood flow velocities and calculated vascular resistance of the OA, CRA and PCA are repeatable.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.